Cardiorentis
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+41 417486030Website
www.cardiorentis.comRevenue
<$5 MillionIndustry
About Cardiorentis
Is Cardiorentis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cardiorentis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cardiorentis
Check out if Cardiorentis is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cardiorentis has new funding data
Check if Cardiorentis has recently received funding, and reach out quickly before it becomes old news!
Cardiorentis, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cardiorentis launches new products
Earning: See what the market has to say on Cardiorentis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cardiorentis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardiorentis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardiorentis.
Cardiorentis financials insights
Gather financial insights about Cardiorentis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$58.3M
Series B
$60M
Cardiorentis Tech Stack
A closer look at the technologies used by Cardiorentis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardiorentis
Cardiorentis is a private biopharmaceutical company headquartered in Zug, Switzerland. The company is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases. Cardiorentis' disease-based technology platform integrates expertise in protein biology to identify novel targets and rationally design sma... Read More